Navigation Links
Texas Biotech Firms Receive More Than $35 Million in Federal Grants and Credits
Date:11/4/2010

AUSTIN, Texas, Nov. 4, 2010 /PRNewswire/ -- One-hundred seventeen Texas biotechnology companies were awarded more than $35 million in federal tax credits and grants yesterday as part of the Qualifying Therapeutic Discovery Project Tax Credit Program administered by the U.S. Department of the Treasury and the National Institutes of Health.

"The Therapeutic Discovery Credit has provided Texas Life Science companies the ability to continue to invest resources into their ongoing research and development activities," said Tom Kowalski, President of the Texas Healthcare and Bioscience Institute (THBI).  "This comes in the form of equipment and personnel.  This tax credit provides a much needed shot in the arm for Texas Life Science Companies to help them weather the tight credit markets."  

The announcement of the awards was made yesterday in Washington, D.C. by Secretary of the Treasury Tim Geithner and Secretary of Health and Human Services Kathleen Sebelius who were also joined by NIH Director Dr. Francis Collins to announce the recipients of the $1 billion in new therapeutic discovery project credits.

"These grants made possible by the Affordable Care Act will not only help to create jobs and bolster the economy but also bring us closer to the next generation of life-saving cures," said NIH Director Dr. Francis Collins.  "The projects funded show significant potential to create new therapies that will address unmet medical needs and bolster the medical countermeasure supply we use to respond to health emergencies."

A total of 2,923 companies specializing in biotechnology and medical research in 47 states and the District of Columbia received awards under the program.  In all, 4,606 applications from these nearly 3,000 companies were awarded funding.

The therapeutic discovery project program is targeted to projects that show significant potential to produce new therapies, address unmet medical needs, reduce
'/>"/>

SOURCE Texas Healthcare & Bioscience Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Texas A&M chemical engineers work could lead to improved DNA analysis
2. Texas A&M veterinary researchers achieve cloning first
3. Texas Tech, U of Utah win Sandia microdevice competition
4. Texas Teen Opts for Stem Cell Therapy, Hopes of Enlisting in Military
5. $250,000 Awarded to Smartfield, Inc. of Lubbock, TX by the Texas Emerging Technology Fund
6. Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program
7. UH Superconductivity Center Receives Texas Emerging Technology Fund Award
8. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
9. Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
10. SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas
11. University of Texas Picosatellite to be launched from space shuttle to begin milestone mission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 Proove Biosciences , ... , presented two scientific posters at the Annual Clinical ... The four-day event was hosted at the Salt Palace ... to educating genetic and genomic professionals on breakthrough advances ... Insomnia: Study on the Role of DAT1 in Risk ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Forensic Technologies and Services ... their offering. This report analyzes the ... US$ Million by the following Segments: Forensic Databases, ... and Others. Annual estimates and forecasts ...
(Date:4/1/2015)... YORK CITY and LONDON , ... market research reports and solutions, MarketResearch.com is pleased to highlight ... be a year of market growth and opportunity for the ... cell company or cord blood bank, competing in the stem ... conditions, predict industry trends, and act on market changes before ...
(Date:3/31/2015)... 2015 CytoSorbents Corporation (NASDAQ CM: CTSO), ... to treat critically-ill and cardiac surgery patients in ... reports financial results for the fiscal year ending ... product revenues were a record $3.1M, an increase ... revenues of $0.8M Highlights for the Year Ending ...
Breaking Biology Technology:Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 3Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 4Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 5Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 6Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 7MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11
... Pharmaceuticals, Inc.,a privately held biopharmaceutical company developing anti-inflammatory,drugs, ... varespladib (A-002) at,the American Heart Association (AHA) Annual ... Phase II trials in varespladib for the,treatment of ... and its,collaborators released new data from the Phase ...
... November 11 , - Revenues Expected to be ... The Binding Site Limited ("The Binding Site" or the ... update for the year ended 30th September 2008. The ... Revenues are expected to be GBP38.9 million, representing ...
... Cardium Therapeutics,(Amex: CXM ) today reported financial results and ... revised business strategies,for its three operating units: (1) InnerCool Therapies, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), ... InnerCool ...
Cached Biology Technology:Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 2The Binding Site Announces Trading Update for Year Ended September 30th 2008 3Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 2Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 3Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 4Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 5Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 6Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 7Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 8Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 9Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 10Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 11
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has announced ... 2015-2019" report to their offering. The ... at a CAGR of 23.5 percent over the period ... and the growth prospects of the Global Iris Recognition ... size, the report considers the revenue generated from sales ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... by Scripps Research Professor Benjamin Cravatt, Ph.D., is ... The Journal of Biological Chemistry. , The new ... suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines ... The high activity of the enzyme a/b hydrolase4 ...
... bacteria, viruses and other dangerous substances in hospitals, airplanes ... easy as wiping a napkin or paper towel across ... "It's very inexpensive, it wouldn't require that someone be ... activated for whatever you want to find," said Margaret ...
... specifically targets mutant enzymes or "oncoproteins" that have run ... as these drugs are, cancer cells with their backs ... A major goal of cancer research is to frustrate ... issue of Cancer Cell, investigators at the Salk Institute ...
Cached Biology News:Study shows enzyme builds neurotransmitters via newly discovered pathway 2Biodegradable napkin -- featuring sensitive nanofibers -- may quickly detect biohazards 2Distinguishing friend from foe in the battle against cancer 2Distinguishing friend from foe in the battle against cancer 3
LTBP-2 (7B10)...
... polyclonal to Kv4.2 Immunogen Synthetic ... to amino acids 23-43 of Rat Kv4.2. ... Rat.Expected to cross-react with Human (100% identity ... Rabbit (100% identity with immunogen) and Ferret ...
Mouse Anti-Gemin2...
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: